耐药高血压患者四重单药组合的抗高血压疗效:随机,开放,交叉试验的研究方案
Yuanyuan Yao1, Xin Zhang1, Runyu Ye1
1Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Trials
|January 20, 2025
概括
本研究将一种新的组合疗法与抗性高血压 (RH) 的标准治疗进行比较. 这种新的治疗方案旨在在RH患者中更好地降低血压.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 耐性高血压 (RH) 影响患者无控血压 (BP) 尽管多种抗高血压药物,增加心血管风险.
- 矿物质皮质类受体抗剂 (MRA) 是RH的第四线治疗方法,但许多患者无法达到BP目标.
- 传统中医药的复合剂reserpine和triamterene片,由于已证明的抗高血压作用和安全性,在治疗RH方面表现有前途.
研究的目的:
- 为了评估复合储和三丁片作为治疗耐药高血压的疗效.
- 为了在RH患者中比较一种新型治疗方案 (奥尔梅沙坦/阿姆洛迪平 + 复合式储和三亚特片) 与标准治疗方案 (奥尔梅沙坦/阿姆洛迪平 + 印达帕米德 + 螺旋).
主要方法:
- 一个随机交叉临床试验,涉及40名RH患者.
- 参与者将接受两次6周的治疗期,中间有4周的洗期.
- 主要结局是6周后平均24小时缩血压的降低.
主要成果:
- 该部分尚未提供,因为研究仍在进行中.
结论:
- 这项研究将确定复合剂reserpine和triamterene片剂疗法是否与标准治疗相比,在RH患者中提供优异的血压降低.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
Antihypertensive Drugs: Angiotensin II Receptor Blockers
614
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
614
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
142
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
142
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
510
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
510
Antihypertensive Drugs: Thiazide-Class Diuretics
563
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
563


